These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18363512)

  • 21. The role of immune response in initiation and progression of chronic kidney disease.
    Shahbazi M; Smailnejad Ganji K; Mirzakhani M; Mohammadnia-Afrouzi M; Akbari R
    Iran J Kidney Dis; 2019 Sep; 13(5):283-299. PubMed ID: 31705744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial and Cellular Inflammation in Patients with CKD.
    Bernelot Moens SJ; Verweij SL; van der Valk FM; van Capelleveen JC; Kroon J; Versloot M; Verberne HJ; Marquering HA; Duivenvoorden R; Vogt L; Stroes ES
    J Am Soc Nephrol; 2017 Apr; 28(4):1278-1285. PubMed ID: 27799487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives.
    Kreiner FF; Kraaijenhof JM; von Herrath M; Hovingh GKK; von Scholten BJ
    Expert Rev Clin Immunol; 2022 Apr; 18(4):377-389. PubMed ID: 35212585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LDL-cholesterol lowering and renal outcomes.
    Waters DD
    Curr Opin Lipidol; 2015 Jun; 26(3):195-9. PubMed ID: 25887677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.
    Almquist T; Jacobson SH; Mobarrez F; Näsman P; Hjemdahl P
    Eur J Clin Invest; 2014; 44(3):276-84. PubMed ID: 24720535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigational therapies for renal disease-induced anemia.
    Schmid H; Jelkmann W
    Expert Opin Investig Drugs; 2016 Aug; 25(8):901-16. PubMed ID: 27122198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geriatric Nutritional Risk Index Is Associated with Unique Health Conditions and Clinical Outcomes in Chronic Kidney Disease Patients.
    Lin TY; Hung SC
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31739530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.
    Papademetriou V; Lovato L; Tsioufis C; Cushman W; Applegate WB; Mottle A; Punthakee Z; Nylen E; Doumas M;
    Am J Nephrol; 2017; 45(2):136-145. PubMed ID: 27992863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoxyl sulfate: a candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease.
    Barisione C; Ghigliotti G; Canepa M; Balbi M; Brunelli C; Ameri P
    Curr Drug Targets; 2015; 16(4):366-72. PubMed ID: 25537654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and optimization strategies for the development of new drugs that treat chronic kidney disease.
    Ramos AM; Fernández-Fernández B; Pérez-Gómez MV; Carriazo Julio SM; Sanchez-Niño MD; Sanz A; Ruiz-Ortega M; Ortiz A
    Expert Opin Drug Discov; 2020 Jan; 15(1):101-115. PubMed ID: 31736379
    [No Abstract]   [Full Text] [Related]  

  • 33. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin use in patients with diabetes and kidney disease: the Japanese experience.
    Koya D; Campese VM
    J Atheroscler Thromb; 2013; 20(5):407-24. PubMed ID: 23518468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5.
    Marques GL; Hayashi S; Bjällmark A; Larsson M; Riella M; Olandoski M; Lindholm B; Nascimento MM
    Sci Rep; 2021 Jan; 11(1):2473. PubMed ID: 33510348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Kidney Disease-Associated Inflammation Increases the Risks of Acute Kidney Injury and Mortality after Cardiac Surgery.
    Casas A; Mallén A; Blasco-Lucas A; Sbraga F; Guiteras J; Bolaños N; Castaño E; Torras J; Cruzado JM; Navarro E; Hueso M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33353159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withaferin A protects against endoplasmic reticulum stress-associated apoptosis, inflammation, and fibrosis in the kidney of a mouse model of unilateral ureteral obstruction.
    Chen CM; Chung YP; Liu CH; Huang KT; Guan SS; Chiang CK; Wu CT; Liu SH
    Phytomedicine; 2020 Dec; 79():153352. PubMed ID: 33007732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.